Human growth hormone (Pacira Pharmaceuticals)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman growth hormone (Pacira Pharmaceuticals)
Drug Alias NamehGH - PaciraSomatropin
ClassificationBiologics
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPacira Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPacira Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsGrowth Disorders

Other Information

ATC CodeN/A
Related LinksN/A